Engel LS - Search Results

1

Collagen shields containing tobramycin for sustained therapy (24 hours) of experimental Pseudomonas keratitis.

Clinch TE, Hobden JA, Hill JM, O'Callaghan RJ, Engel LS, Kaufmann HE. Clinch TE, et al. Among authors: engel ls. CLAO J. 1992 Oct;18(4):245-7. CLAO J. 1992. PMID: 1424060

2

Efficacy of tobramycin drops applied to collagen shields for experimental staphylococcal keratitis.

Callegan MC, Engel LS, Clinch TE, Hill JM, Kaufman HE, O'Callaghan RJ. Callegan MC, et al. Among authors: engel ls. Curr Eye Res. 1994 Dec;13(12):875-8. doi: 10.3109/02713689409015089. Curr Eye Res. 1994. PMID: 7720394

3

Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis.

Engel LS, Callegan MC, Hobden JA, Reidy JJ, Hill JM, O'Callaghan RJ. Engel LS, et al. Curr Eye Res. 1995 Mar;14(3):229-34. doi: 10.3109/02713689509033519. Curr Eye Res. 1995. PMID: 7796606

4

Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis.

Callegan MC, Engel LS, Hill JM, O'Callaghan RJ. Callegan MC, et al. Among authors: engel ls. Invest Ophthalmol Vis Sci. 1994 Mar;35(3):1033-7. Invest Ophthalmol Vis Sci. 1994. PMID: 8125714

5

Age and therapeutic outcome of experimental Pseudomonas aeruginosa keratitis treated with ciprofloxacin, prednisolone, and flurbiprofen.

Hobden JA, Hill JM, Engel LS, O'Callaghan RJ. Hobden JA, et al. Among authors: engel ls. Antimicrob Agents Chemother. 1993 Sep;37(9):1856-9. doi: 10.1128/AAC.37.9.1856. Antimicrob Agents Chemother. 1993. PMID: 8239596 Free PMC article.

6

Pseudomonas aeruginosa keratitis in leukopenic rabbits.

Hobden JA, Engel LS, Callegan MC, Hill JM, Gebhardt BM, O'Callaghan RJ. Hobden JA, et al. Among authors: engel ls. Curr Eye Res. 1993 May;12(5):461-7. doi: 10.3109/02713689309024628. Curr Eye Res. 1993. PMID: 8344069

7

Prednisolone acetate or prednisolone phosphate concurrently administered with ciprofloxacin for the therapy of experimental Pseudomonas aeruginosa keratitis.

Hobden JA, Engel LS, Hill JM, Callegan MC, O'Callaghan RJ. Hobden JA, et al. Among authors: engel ls. Curr Eye Res. 1993 May;12(5):469-73. doi: 10.3109/02713689309024629. Curr Eye Res. 1993. PMID: 8344070

8

Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence.

O'Callaghan RJ, Engel LS, Hobden JA, Callegan MC, Green LC, Hill JM. O'Callaghan RJ, et al. Among authors: engel ls. Invest Ophthalmol Vis Sci. 1996 Mar;37(4):534-43. Invest Ophthalmol Vis Sci. 1996. PMID: 8595953

9

The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis.

Engel LS, Callegan MC, Hill JM, Folkens AT, Shimomura Y, O'Callaghan RJ. Engel LS, et al. Jpn J Ophthalmol. 1996;40(2):212-9. Jpn J Ophthalmol. 1996. PMID: 8876389

10

Pseudomonas deficient in protease IV has significantly reduced corneal virulence.

Engel LS, Hobden JA, Moreau JM, Callegan MC, Hill JM, O'Callaghan RJ. Engel LS, et al. Invest Ophthalmol Vis Sci. 1997 Jul;38(8):1535-42. Invest Ophthalmol Vis Sci. 1997. PMID: 9224281

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters